Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Terra Tech’s CEO, CFO, COO, and Directors Dump Stock Ahead of Future Reverse Splits

Sep 27, 2017 • 1:52 PM EDT
Canada Stocks (34).png
2 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Typically, when company insiders are selling stock, they know something…

This 100% seems to be the case over at Terra Tech (TRTC) and the market seems to have recognized this.

Over the last month, the senior management team at Terra Tech have dumped millions-on-millions stock and yesterday’s disclosure helps explain why.

Yesterday, Terra Tech filed an 8-K after the shareholders approved an amendment to implement one or more reverse stock splits at an aggregate ratio of not less than 1-for-5 and not more than 1-for-50.

The Board of Directors have full discretion to conduct these splits at any time or from time-to-time prior to September 25, 2018.

Terra Tech Directors Join the Insider Selling Party

Last week, we published an article that discussed some of the heavy insider selling taking place at Terra Tech.

Over the last two weeks, CEO Derek Peterson sold more than 3 million shares while CFO Michael James dumped 700,000 shares.

It looks like some of the other directions wanted to join in on this party and earlier this week, more members of management disclosed insider sales. Some of the transactions to highlight include:

  • COO Ken VandeVrede sold 400,000 shares last week and still owns more than 9.3 million shares. We expect to see more selling in near future.
  • Director Steven Ross dumped 200,000 shares last week and we expect to see him sell off his remaining 1.8 million shares.

A Downward Spiral  

Over the last few years, we have been cautious with Terra Tech and think that the company has too much on its plate. Terra Tech was one of the first publicly traded cannabis companies and has a significant following.

After Terra Tech reported its second quarter financial results in August, CEO Derek Peterson said that he expects the company to generate between $38 million and $40 million in revenue in 2017. For this reason, we find the reverse split and recent sales to be major red flags.

When a company like Terra Tech (which is supposed to be in the middle of a major turnaround) reports such large sales by its CEO and CFO, it raises significant doubt about the company’s future.

Terra Tech has a long history of not acting in shareholders’ best interests and we plan to proceed with caution.

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.